["{\n\"step_by_step_thinking\": \"Based on the patient's symptoms and ECG results, it appears that he has atrial fibrillation with no P-waves. Given his history of myocardial infarction and current medications, including captopril, metoprolol, and atorvastatin, it is likely that this new medication is an anticoagulant to reduce the risk of stroke or systemic embolism associated with atrial fibrillation. The patient's laboratory results show no indication of liver or kidney dysfunction, which would have affected the metabolism of the anticoagulant. Therefore, I conclude that the mechanism by which this new medication will exert its effects is most likely through C: Inhibition of vitamin K-dependent clotting factors.\",\n\"answer_choice\": C"]